Meeting with QazBioPharm National Holding JSC

On 24 January 2024, Astana hosted a meeting between the BeNeLux Chamber of Commerce in Kazakhstan and QazBioPharm National Holding JSC. Representing the Chamber were General Director Anuar Kurzhikayev, Deputy General Director L.Ye. Doldyrina, and General Secretary I.S. Li. The Holding was represented by General Director Ye.O. Abduraimov, Deputy General Director for Science, Commercialisation and Production A.S. Rsaliyev, Adviser to the General Director on Biological Safety R.F. Kamenov, Director of the International Cooperation, Marketing and Promotion Department B.B. Abit, and Head of the International Cooperation Department M.N. Bekzhanov.

The meeting addressed preparations for the upcoming trade mission of Kazakh medical and pharmaceutical institutes and companies to Belgium, with visits to the production sites of companies such as Catalent, Janssen and UCB, as well as Ghent University Hospital, on 10–13 March 2024.

The parties also discussed an event planned for February 2024 to present the Holding and its 8 affiliated companies to the Ambassadors of EU member states who are Chamber members.

At the close of the meeting, the heads of the two organisations signed a memorandum of understanding and cooperation between QazBioPharm National Holding JSC and the BeNeLux Chamber of Commerce Association in the Republic of Kazakhstan. The memorandum aims to establish and develop cooperation and to promote trade and investment opportunities within their respective competencies.

The parties also plan to strengthen business, scientific and technical cooperation and partnership in the biopharmaceutical sector with the BeNeLux countries (the Kingdom of Belgium, the Kingdom of the Netherlands and the Grand Duchy of Luxembourg), aimed at developing and promoting Kazakh pharmaceutical, medicinal and veterinary products on foreign markets, as well as attracting European pharmaceutical companies to manufacture in Kazakhstan.

Background:
QazBioPharm National Holding JSC is a company under the Ministry of Health of the Republic of Kazakhstan, wholly state-owned, established to ensure biological safety, sustainable development and improvement of the biopharmaceutical market infrastructure, to stimulate the development of biopharmaceutical science and industry, to meet the needs of the state and society for biopharmaceutical products, and to coordinate interagency cooperation on biological safety.